Stocks Hitting 52-Week Lows

shares touched a new 52-week low of $3.675. Zosano Pharma reported that it has discontinued the development of its Daily ZP-PTH treatment for severe osteoporosis and will resume development of its Weekly ZP-PTH product. The company also decided to terminate the collaboration with

.

shares reached a new 52-week low of $5.15. Veracyte's trailing-twelve-month ROE is -59.56 percent.

shares declined 1.33 percent to reach a new 52-week low of $9.68. AES shares have dropped 30.82 percent over the past 52 weeks, while the S&P 500 index has declined 4.59 percent in the same period.

shares touched a new 52-week low of $3.52. Universal Technical Institute's PEG ratio is 4.59.